Showing results (91-100 of 439) with videos related to
Sort By:
Pageof 44
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 21, 2010
B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cellsJonathan Skupsky, Ai-Hong Zhang, Yan Su, et al.Human Gene Therapy|July 24, 2010
Gene therapy with IgG-HY fusion proteins to reduce male-specific T-cell reactivity in vitroMiranda P Dierselhuis, Ellen Schrama, David W Scott, et al.Trends in Molecular Medicine|August 12, 2009
Gene therapy and bone marrow stem-cell transfer to treat autoimmune diseaseFrank Alderuccio, James Chan, David W Scott, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|June 27, 2017
Hemophilia A inhibitor treatment: the promise of engineered T-cell therapyKalpana Parvathaneni, Maha Abdeladhim, Kathleen P Pratt, et al.Blood|October 2, 2009
A role for thrombin in the initiation of the immune response to therapeutic factor VIIIJonathan Skupsky, Ai-Hong Zhang, Yan Su, et al.Cancer Discovery|July 4, 2020
Toward a New Molecular Taxonomy of Diffuse Large B-cell LymphomaDaisuke Ennishi, Eric D Hsi, Christian Steidl, et al.Journal of Cellular Physiology|August 19, 2004
Increased GADD gene expression in human colon epithelial cells exposed to deoxycholateDavid W Scott, Sophia Mutamba, Robin G Hopkins, et al.Current Gene Therapy|November 6, 2007
Tolerance induction by gene transfer to lymphocytesJonathan Skupsky, Yan Su, Tie-Chi Lei, et al.Blood|November 15, 2014
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroupFong Chun Chan, Adele Telenius, Shannon Healy, et al.Blood|December 15, 2011
Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphomaSarah T Wilkinson, Kristie A Vanpatten, Diane R Fernandez, et al.Pageof 44